Company registration number 07874760 (England and Wales)
CUTTING EDGE SURGERY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
CUTTING EDGE SURGERY LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
CUTTING EDGE SURGERY LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
as restated
Notes
£
£
£
£
Fixed assets
Tangible assets
4
71,879
93,549
Current assets
Debtors
5
456,593
305,332
Cash at bank and in hand
30,793
84,390
487,386
389,722
Creditors: amounts falling due within one year
6
(110,962)
(98,500)
Net current assets
376,424
291,222
Total assets less current liabilities
448,303
384,771
Creditors: amounts falling due after more than one year
7
(72,126)
(92,065)
Provisions for liabilities
(1,925)
(11,413)
Net assets
374,252
281,293
Capital and reserves
Called up share capital
8
6
6
Share premium account
5,509
5,509
Profit and loss reserves
368,737
275,778
Total equity
374,252
281,293
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
For the financial year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
CUTTING EDGE SURGERY LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2024
31 December 2024
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 30 September 2025 and are signed on its behalf by:
Ms J Thom
Director
Company Registration No. 07874760
CUTTING EDGE SURGERY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -
1
Accounting policies
Company information
Cutting Edge Surgery Limited is a private company limited by shares incorporated in England and Wales. The registered office is Montefiore Hospital, 2 Montefiore Road, Hove, East Sussex, United Kingdom, BN3 1RD.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
1.3
Intangible fixed assets - goodwill
Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Plant and equipment
25% Reducing balance
Fixtures and fittings
25% Reducing balance
Computers
25% Reducing balance
Motor vehicles
25% Reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.5
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
CUTTING EDGE SURGERY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 4 -
1.6
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.7
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.8
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.9
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
1.10
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.11
Leases
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.
CUTTING EDGE SURGERY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 5 -
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2024
2023
Number
Number
Total
1
1
3
Intangible fixed assets
Goodwill
£
Cost
At 1 January 2024 and 31 December 2024
135,000
Amortisation and impairment
At 1 January 2024 and 31 December 2024
135,000
Carrying amount
At 31 December 2024
At 31 December 2023
4
Tangible fixed assets
Plant and equipment
Fixtures and fittings
Computers
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 January 2024
62,857
9,109
6,254
111,514
189,734
Additions
2,154
2,154
Disposals
(415)
(415)
At 31 December 2024
62,857
9,109
7,993
111,514
191,473
Depreciation and impairment
At 1 January 2024
58,953
7,573
2,357
27,302
96,185
Depreciation charged in the year
976
384
1,269
21,053
23,682
Eliminated in respect of disposals
(273)
(273)
At 31 December 2024
59,929
7,957
3,353
48,355
119,594
Carrying amount
At 31 December 2024
2,928
1,152
4,640
63,159
71,879
At 31 December 2023
3,904
1,536
3,897
84,212
93,549
CUTTING EDGE SURGERY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 6 -
5
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
27,988
21,179
Other debtors
291,368
152,310
319,356
173,489
2024
2023
Amounts falling due after more than one year:
£
£
Other debtors
137,237
131,843
Total debtors
456,593
305,332
6
Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans
10,268
10,014
Taxation and social security
81,739
57,239
Other creditors
18,955
31,247
110,962
98,500
7
Creditors: amounts falling due after more than one year
2024
2023
£
£
Bank loans and overdrafts
9,641
19,908
Other creditors
62,485
72,157
72,126
92,065
8
Called up share capital
2024
2023
£
£
Ordinary share capital
Issued and fully paid
2 Ordinary A Shares of £1 each
2
2
2 Ordinary B Shares of £1 each
2
2
1 Ordinary C Share of £1 each
1
1
1 Ordinary D Share of £1 each
1
1
6
6
CUTTING EDGE SURGERY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 7 -
9
Related party transactions
The following amounts were outstanding at the reporting end date:
2024
2023
Amounts due from related parties
£
£
Other related parties
173,923
169,491
The above loans are unsecured, interest free and have no fixed repayment terms.
10
Directors' transactions
At the balance sheet date, there was an amount due from directors of £225,367 (2023 amount due from directors of £85,133). This loan is interest free, unsecured and no repayment terms have been established.
11
Prior period adjustment
As at 31 December 2023, motor vehicle additions and hire purchase liability was overstated by £21,833.
Reconciliation of changes in equity
1 January
31 December
2023
2023
£
£
Adjustments to prior year
Motor vehicle additions
-
(21,833)
Hire purchase
-
21,833
Hire purchase interest
-
(932)
Corporation tax
-
(160)
Deferred tax
-
(469)
Depreciation
-
3,184
Total adjustments
-
1,623
Equity as previously reported
222,367
279,670
Equity as adjusted
222,367
281,293
Analysis of the effect upon equity
Profit and loss reserves
-
1,623
CUTTING EDGE SURGERY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
11
Prior period adjustment
(Continued)
- 8 -
Reconciliation of changes in profit for the previous financial period
2023
£
Adjustments to prior year
Hire purchase interest
(932)
Corporation tax
(160)
Deferred tax
(469)
Depreciation
3,184
Total adjustments
1,623
Profit as previously reported
170,123
Profit as adjusted
171,746
2024-12-312024-01-01falsefalsefalse30 September 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityMs J ThomMr S J Watts078747602024-01-012024-12-31078747602024-12-31078747602023-12-3107874760core:PlantMachinery2024-12-3107874760core:FurnitureFittings2024-12-3107874760core:ComputerEquipment2024-12-3107874760core:MotorVehicles2024-12-3107874760core:PlantMachinery2023-12-3107874760core:FurnitureFittings2023-12-3107874760core:ComputerEquipment2023-12-3107874760core:MotorVehicles2023-12-3107874760core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3107874760core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3107874760core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3107874760core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3107874760core:CurrentFinancialInstruments2024-12-3107874760core:CurrentFinancialInstruments2023-12-3107874760core:Non-currentFinancialInstruments2024-12-3107874760core:Non-currentFinancialInstruments2023-12-3107874760core:ShareCapital2024-12-3107874760core:ShareCapital2023-12-3107874760core:SharePremium2024-12-3107874760core:SharePremium2023-12-3107874760core:RetainedEarningsAccumulatedLosses2024-12-3107874760core:RetainedEarningsAccumulatedLosses2023-12-3107874760core:ShareCapitalOrdinaryShareClass12024-12-3107874760core:ShareCapitalOrdinaryShareClass12023-12-3107874760core:ShareCapitalOrdinaryShareClass22024-12-3107874760core:ShareCapitalOrdinaryShareClass22023-12-3107874760core:ShareCapitalOrdinaryShareClass32024-12-3107874760core:ShareCapitalOrdinaryShareClass32023-12-3107874760core:ShareCapitalOrdinaryShareClass42024-12-3107874760core:ShareCapitalOrdinaryShareClass42023-12-3107874760core:ShareCapitalOrdinaryShares2024-12-3107874760core:ShareCapitalOrdinaryShares2023-12-3107874760bus:Director12024-01-012024-12-3107874760core:Goodwill2024-01-012024-12-3107874760core:PlantMachinery2024-01-012024-12-3107874760core:FurnitureFittings2024-01-012024-12-3107874760core:ComputerEquipment2024-01-012024-12-3107874760core:MotorVehicles2024-01-012024-12-31078747602023-01-012023-12-3107874760core:Goodwill2023-12-3107874760core:Goodwill2024-12-3107874760core:Goodwill2023-12-3107874760core:PlantMachinery2023-12-3107874760core:FurnitureFittings2023-12-3107874760core:ComputerEquipment2023-12-3107874760core:MotorVehicles2023-12-31078747602023-12-3107874760core:WithinOneYear2024-12-3107874760core:WithinOneYear2023-12-3107874760core:AfterOneYear2024-12-3107874760core:AfterOneYear2023-12-3107874760bus:PrivateLimitedCompanyLtd2024-01-012024-12-3107874760bus:SmallCompaniesRegimeForAccounts2024-01-012024-12-3107874760bus:FRS1022024-01-012024-12-3107874760bus:AuditExemptWithAccountantsReport2024-01-012024-12-3107874760bus:Director22024-01-012024-12-3107874760bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP